History
- MayAcquires Re-Certification for Anti-bribery management system (ISO37001)
- NovWins 'Minister of Health and Welfare Prize’ at Korea Innovative Pharmaceutical Company Awards 2022
- DecWins Director of of Gyeongin Regional Korea Food Drug Administration Prize at Food and Drug Safety Management Award 2022
- AprLaunches Mucosta SR 150mg
- JuneAcquires Korea Innovative Pharmaceutical Company Re-certification accredited by the Ministry of Health and Welfare
- JuneWins Chairperson of Korea Fair Trade Commission Prize at 'The 15th National Sustainability Management Conference'
- DecWins the Minister of Food and Drug Safety Award at 35 th Medicine day
- OctLaunches Innersignal, Cosmetics for women
- MarWins ' Presidential citation' at 46th Commerce and Industry Commemoration Day 2019
- AprLaunches PletaalSR 200mg
- JuneAcquires Certification for Anti-bribery management system (ISO37001)
- NovWins 'Minister of Health and Welfare Prize’ a t 33 th Medicine day
- MarLaunches Naturemade, health functional food
- Apr Selected as Digital Medison Manufacturing Site for Hyangnam Factory
- JunLaunches ICLUSIG Tab
- JunAcquires Korea Innovative Pharmaceutical Company Re-certification accredited by the Ministry of Health and Welfare
- JulReauthorized as ‘mother-friendly workplace’ selected by unicef
- NovWins 'Minister of Health and Welfare Prize’ at Korea Innovative Pharmaceutical Company Awards 2017
- MarWins Seoul Meritorious Taxpayer Commendation
- AprUL · OS Wins Silver Prize at Effie Awards Korea
- SepLaunches Abilify Maintena for Injection 300mg and 400mg
- NovAcquires Gyeonggi Good Work Place (GGWP) Re-certification
- NovWins 'Korea Health Industry Development Institute President Prize' at Korea Innovative Pharmaceutical Company Awards 2016
- JanLaunches UBIT Tab and POCone
- AprUL · OS Wins Gold Prize at Effie Awards Korea
- JunAcquires Korea Innovative Pharmaceutical Company Re-certification accredited by the Ministry of Health and Welfare
- JulWins Encouragement Prize at Business Practice and Culture Improvement Contest 2015 hosted by Gangnam Office of Ministry of Employment and Labor
- SepWins Mayor of Gwangmyeong Prize at Social Welfare Day Ceremony
- NovReleases Deltyba Tab 50mg
- NovWins Grand Prize at Sejong Sharing Volunteer Awards 2015
- DecObtains an Additional Indication for Prohibition of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Progression (Samsca Tab)
- DecWins 30 Million Dollar Export Tower Award and Industrial Service Medal at the 52nd Trade Day Ceremony
- JanHyangnam Factory Acquires Approval for Abilify ODT and OS EU-GMP
- FebSigns a Memorandum of Understanding (MOU) with the Ministry of Health and Welfare
- JulAnnounces Vision2018
- AugAcquires 'Mother-friendly Workplace' Certification accredited by UNICEF
- DecWins Grand Prize at Sejong Sharing Volunteer Awards 2014
- JanUL · OS Wins Grand Prize at Brand of the Year Korea Awards
- JanLaunches Samsca Tab 15mg and 30mg
- JanHyangnam Factory Expands Abilify ODT& OS Production Line
- AprLaunches Busulfex for Injection
- MayUL · OS Wins Grand Prize at the Korea Consumer Satisfaction Award for second year running
- DecSelected as One of Top 10 Gyeonggi Good Work Places (GGWP)
- MarLaunches UL · OS, Cosmetics for Men
- JunUL · OS Wins Grand Prize at Customer Quality Satisfaction Awards 2012
- JunSelected as a Korea Innovative Pharmaceutical Company accredited by the Ministry of Health and Welfare
- AugHyangnam Factory Expands Administration Building
- NovSelected as a Korea Representative Best Enterprise of 2012 by Maeil Kyungjae
- DecSelected as a Best Family Friendly Management by the Ministry of Gender Equality and Family. Wins Prime Minister's Commendation.
- MarLaunches Abilify Tab 2mg
- AprHyangnam Factory Wins Minister of Employment and Labor Prize as a Company with Excellent Gender Equality Culture
- MayLaunches PletaalSR 100mg
- MayStarts to Produce and Ship Clinical Drugs
- JunWins Grand Prize for Contribution in Health and Welfare at Add Happiness CSR Awards
- SepInaugurates Moon, Sung-ho as President
- SepStarts Healthcare Business Division
- NovAbilify Tab Acquires Approval to be Used for Children and Young People (For Tourette Syndrome and Other Indications)
- MarHyangnam Factory extends Clinical Drug Production Line
- AprCompletes and Moves to the HQ Building (Otsuka Vision Building) in Yeoksam-dong
- JunOpens Saemmool Hall (Place for Collecting Autonomous Social Contribution Fund by Officers and Employees)
- SepSigns an Agreement with the Gwangmyoeng Community Welfare Center for Community Service Activities
- OctOpens Gangwon Office
- NovHyangnam Factory Acquires Certification for Occupational Health and Safety Management System
- DecSelected as One of the Top 10 Gyeonggi Good Work Places (GGWP). Wins Grand Prize.
- DecPresident Eom, Dae-sik Wins 'Gyeonggi Best Manager Award'
- DecHyangnam Factory Wins Grand Prize at the Gyeonggi Environment Green Awards
- SepSign a MOU with Ministry of Health of Korea
- NovWin a prize of 20 mil. Export and industrial package in 46th ATD
- DecWin National Competitiveness Contribution Award
- MarInitiated 3R (Reduce, Recycle, Reuse) Policy in the company
- AprIntroduced new CI
- JulObtained an additional indication for the ‘Adjunctive Treatment of Major Depressive Disorder in Adults’ (Abilify tablets)
- AugObtained approval for 2mg Abilify tablets
- OctHyangnam factory receives the highest grade in the 2008 PSM (Process Safety Management) inspection
- OctAcquired drug and price approval for Mikelan LA eye drop 1, 2%
- DecHyangnam Factory acquires ISO14001 certification
- DecAnnounced mid to long term vision 'TMB3000
- MarReceived pharmaceutical manufacturer approval from Ministry of Health, Pakistan
- MayStarted Meptin Swinghaler sales
- SepInitiated ERP system in the company
- NovConstructed warehouse and expands manufacturing facilities in Hyangnam Factory
- JanStarted Abilify 5mg tablets sales
- AprReceived pharmaceutical manufacturer approval from MOH, Egypt
- MayStarted OBUCORT Swinghaler
- JulEstablished the company welfare fund
- AprAbilify 5mg tablets become reimbursable
- MayReceives the highest grade in 2004 PSM (Process Safety Management) (The only one among 17 other new companies that were inspected by the Ministry of Labor in Suwon Province)
- SepCompletes the reporting of DMF (Drug Master File) for Hyangnam Factory (Cilostazol and Rebamipide)
- SepObtains an additional indication for the treatment of bipolar disorder (Abilify tablets )
- FebObtains approval for Abilify tablets
- AprLaunches Abilify tablets 10mg, 15mg
- JulChange of address (Woori Building => Kukje Electronics Center Building)
- JanStarts exportation of Mucosta tablets Philippines
- JulAnnounces ‘Vision 2008' to achieve 100 billion Won in sales
- sepStarts exportation of Cilostazol Taiwan
- OctRebamipide compound plant completed
- OctObtains an additional indication for the prevention of cerebral infarction recurrence(Pletaal tablets )
- JanObtains import approval for Adacircuit (Medical Device)
- AprInitiates clinical trial for Ulcer Colitis with Adacolumn
- AugReceives manufacturing product approval for Abilify under the condition of clinical trial obtained
- AugAll of KOP's Medical Representatives passes the MR certifying test by KPMA
- SepInitiates the construction of Rebamipide compound plant
- MayLaunches UBIT, UBiT-IR 300
- OctChange of address (Chunji Building -> Woori Building )
- DecRaises the Jeonju branch office to Jeonju office
- JulReceives FDA approval(Clostazol)
- OctReceives GMP approval for raw material
- NovObtains UBIT certification
- FebOpens Jeonju branch office
- MarOpens Masan branch office
- MayReceives product sales approval (Lungaskin 200mg tablets)
- NovWinning of the 10 million Export Prize and the Order of Industrial Merit
- DecReceives product sales approval(UBIT)
- AprSets up Intranet System
- SepInaugurates EOM, Dae-sik as President Compound facility in Hyangnam factory completed
- Dec(GMP facility of raw material production)
- JulStarts exportation of Aminoleban EN 50g powder to Hong Kong
- AprStarts exportation of Pletaal 50mg tablets to Philippines
- AprImports food business report
- MarInitiates production of raw material compound (Cilostazol)
- JulOpens Daejeon office
- JulReceives product sales approval (Mucosta)
- AugStarts exportation of Cilostazol to Japan
- JanOpens Busan and Daegu office
- MarReceives product sales approval (Pletaal tablets 50mg, 100mg)
- JulOpens Gwangju office
- JulReceives raw material product approval (Cilostazol)
- SepReceives product sales approval (Mikelan Eye Drop 1%, 2%)
- OctChanges name to Korea Otsuka Pharmaceutical Co., Ltd.
- DecReceives KGMP approval for the Hyangnam factory
- SepIncreases capital (5.24 billion Won)
- SepKGMP factory construction completed (Hyangnam Pharmaceutical Complex)
- NovReceives pharmaceutical manufacturer approval from Ministry of Health & Welfare
- NovObtains product sales approval (Meptin tablets, Mikelan tablets, Aminoleban EN powder)
- MayObtains export & import business approval from Ministry of Commerce & Industry
- AugReceives export & import approval for pharmaceutical product from Ministry of Health & Welfare
- SepReceives manufacturer approval for Pharmaceutical raw material from Ministry of Health & Welfare
- NovItiate production of raw material
- MarReceives foreign investment approval from Ministry of Finance
- JulJointly establishes Jeil Otsuka Pharmaceutical Co., Ltd.
